CT (Lux) European Growth & Income A GBP

Reference Data

ISIN LU0515381027
Valor Number 11923354
Bloomberg Global ID BBG001746GZ1
Fund Name CT (Lux) European Growth & Income A GBP
Fund Provider Columbia Threadneedle Investments Web: www.columbiathreadneedle.com
Phone: +352 464 0107 460
E-Mail: Lux-CTenquiries@statestreet.com
Fund Provider Columbia Threadneedle Investments
Representative in Switzerland Reyl & Cie S.A.
Genève
Phone: +41 22 816 80 00
Distributor(s) Banque Cantonale de Genève
Genève 2
Phone: +41 22 317 27 27
Asset Class Bonds
EFC Category
Distribution Policy Distribution
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The investment objective of the Portfolio is to achieve long-term capital appreciation and an enhanced level of income by investing in companies listed on one of the European States Stock Exchanges or a regulated market.
Peculiarities

Fund Prices

Current Price * 28.53 GBP 19.09.2024
Previous Price * 28.17 GBP 18.09.2024
52 Week High * 28.86 GBP 30.08.2024
52 Week Low * 22.88 GBP 23.10.2023
NAV * 28.53 GBP 19.09.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 37,406,988
Unit/Share Assets *** 32,245,134
Trading Information SIX

Performance

YTD Performance +11.14% 29.12.2023
19.09.2024
YTD Performance (in CHF) +16.77% 29.12.2023
19.09.2024
1 month -0.56% 19.08.2024
19.09.2024
3 months +1.97% 19.06.2024
19.09.2024
6 months +6.22% 19.03.2024
19.09.2024
1 year +20.48% 19.09.2023
19.09.2024
2 years +38.29% 20.09.2022
19.09.2024
3 years +28.22% 20.09.2021
19.09.2024
5 years +53.72% 19.09.2019
19.09.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Novo Nordisk A/S Class B 4.80%
ASML Holding NV 4.25%
Roche Holding AG 3.34%
SAP SE 3.33%
Intesa Sanpaolo 3.26%
M&G PLC Ordinary Shares 2.99%
AstraZeneca PLC 2.93%
Phoenix Group Holdings PLC 2.76%
SSE PLC 2.73%
Deutsche Telekom AG 2.63%
Last data update 31.07.2024

Cost / Risk

TER
TER date
Performance Fee ***
PTR
Max. Management Fee *** 2.00%
Ongoing Charges *** 1.82%
SRRI ***
SRRI date *** 31.08.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)